Aurora Cannabis Inc (CVE:ACB) reported that effective immediately, Allan Cleiren has been engaged as Chief Operational Officer. Based in Edmonton, Cleiren will be accountable for synergistic integration of both international and domestic acquisitions, evaluating future prospects for further expansion, while maintaining a healthy balance between protection of shareholder value and growth, and optimization of the firm’s processes and structure with a view of carrying progress while achieving improved operational efficiencies.
Aurora reported that Cleiren has almost three decades of experience in operations and finance management with both publicly and privately held firms in the life sciences, construction, oil and gas service, insurance, rail, and other divisions. Through different senior roles, he has held responsibility for different aspects of operations, counting manufacturing, human resources, IT, marketing and logistics.
As a senior financial executive, Cleiren also extensive experience in restructuring and M&A. Throughout his career, Cleiren’s focus has remained on achieving operational efficiency and excellence, contributing to significant profitability and revenue growth.
Most recently, Cleiren was COO of Jardine Lloyd Thompson Canada Inc., one of the world’s major providers of insurance, employee benefits related advice, reinsurance, brokerage and related services. Before joining JLT, he was Executive Vice President and ex CFO for Universal Rail Systems Inc, and CFO and SVP of Operations for Afexa Life Sciences.
Aurora reported that Cleiren is a CPA, holds a Bachelor of Commerce degree, and also has a Diploma in Management Sciences. He holds a ICD.D status from the Institute of Corporate Directors.
With company expanding within Canada and globally, and the growth of employee base, the company required a multi-talented, multi-faceted businesses professional to further improve its management team. With his diverse and strong background, Cleiren can ensure that Aurora execution continues to fulfill and surpass extremely high internal standards.
In the last trading session, the stock price of Aurora declined more than 3% to close the day at $2.22.
Top Stock Analysis At Journal Transcripthttp://www.journaltranscript.com
Early bird alerts on the hottest OTC companies
2017 Most Disruptive Biotech VBIOhttp://www.financialstrend.com
Disruptive biotech VBIO decodes targeted drug delivery for stem cells
Wall Street PR - BIG BUYOUT OPPORTUNITYhttp://wallstreetpr.com
Here’s how to leverage this breakthrough technology…
Enter The $100 Cannabis Markethttp://www.financialstrend.com
VBIO cannabis industry setup for explosive growth
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of journaltranscript.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure